Lilly triple-G drug cut weight 28.7%, eased knee pain

Eli Lilly's triple-G weight-loss drug cut body weight about 28.7% and eased knee-osteoarthritis pain, MarketWatch reported Dec. 11, 2025. The combination matters: less pain could keep patients on treatment longer and help justify insurance coverage. I'm skeptical that more weight loss automatically means proportionally larger health gains.